Researchers develop a deep learning framework to accelerate ultra-low-field brain MRI, achieving faster scan times and enhanced image quality. The method shows promise in making MRI more accessible and reliable, especially in settings with limited access to high-field scanners.
AbbVie agrees to acquire Nimble Therapeutics for $200m
The deal includes a $200m cash payment from AbbVie at closing, subject to standard adjustments, alongside potential interim funding payments. Credit: © AbbVie Inc. All
December 16, 2024